A low-molecular-weight heparin (LMWH), when anti-IIa activity was compared. In the ex vivo part Tinzaparin, was compared with unfractionated heparin of the study, a significant enhancement of ADP-induced (UFH) for their effects on platelet aggregation in vitro and platelet aggregation was observed after i.v. administra ex vivo. Both heparins showed a dose-dependent proag- tion of both Tinzaparin and UFH with no difference in gregatory effect on ADP- and collagen-induced platelet potency. Subcutaneous administration of Tinzaparin in aggregation in vitro, but LMWH was less potent. The two different doses did not have any effect on platelet differences in potency between Tinzaparin and UFH de- activity. In conclusion, Tinzaparin appears, like other pended on how the compounds were compared. The most LMWHs, to have less proaggregatory effect on platelets pronounced difference was found when molar concentra- than UFH both in vitro and ex vivo.
Chen J., Karlberg KE, Sylvén C.Heparin and low-molecular weight heparin but not hirudin stimulate platelet aggregation in whole blood from acetylsalicylic acid treated healthy volunteers . Thromb Res1991 ;63:319.
2.
Chen J., Karlberg KE, Sylvén C.Heparin enhances platelet aggregation irrespective of anticoagulation with citrate or with hirudin. Thromb Res1992 ;67:253.
3.
Brace LD, Fareed J.Heparin induced platelet aggregation. II. Dose/response relationships for a low molecular weight heparin derivative (PK 10169) and its subfractions . Thromb Res1986;42:769.
4.
Barradas MA, Mikailidis DP, Epemolu O., Jerymy JY, Fonseca V., Dandona P.Comparison of the platelet proaggregatory effect of conventional unfractionated heparins and low molecular weight heparin fraction (CY 222). Br J Haematol1987;67:451.
5.
Mikhailidis DP, Barradas MA, Mikhailidis AM, Magnani H., Dandona P.Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function. Br J Clin Pharmacol1984;17:43.
6.
Salzman EW, Rosenberg RD, Smith MH, Lindon, JN, Favreau L.Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest1980;65:64.
7.
Westwick J., Scully MF, Poll C., Kakker VVComparison of the effects of low molecular weight heparin and unfractioned heparin on activation of human platelets in vitro. Thromb Res1986;42:435.
8.
Landolfi R., De Candia B, Rocca G., Ciabattoui G., Antinori A., Masetti R., Patrono C.Effect of unfractionated and low molecular weight heparin on platelet thromboxane biosynthesis "in vivo". Thromb Haemost1994 ;72:942.
9.
Zucker MBEffects of heparin on platelet function. Thromb Diathes Haemorrh1974;33:63.
10.
Messmore HL , Griffin B., Fareed J., Coyne E., Segathchian J.In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets. Ann NY Acad Sci1989;556:217.
11.
O'Brien JR, Shoobridge SM, Finch WJComparison of the effect of heparin and citrate on platelet aggregation . J Clin Pathol1969;22:28.
12.
Cella G., Scattolo N., Luzzatto G., Girolami A.Effects of low molecular weight heparin on platelets as compared with commercial heparin. Res Exp Med1984;184:227.
13.
Heinrich D. , Görg T., Schulz M.Effects of unfractionated and fractionated heparin on platelet function. Haemostasis1988; 18(suppl 3):48.
14.
Ljungberg B. , Beving H., Egberg N., Johnsson H., Vesterqvist O.Immediate effects of heparin and LMW heparin on some platelets and endothelial derived factors. Thromb Res1988; 51:209.
15.
Sakuragawa N., Takahashi K.Comparative studies on the properties of unfractionated and low molecular weight heparin. Semin Thromb Hemost1990;16(suppl):5.
16.
Born Gvr.Aggregation of blood platelets by adenosine diphosphate and its reversal . Nature1962;194:927.
17.
Hirsh J.Heparin. N Engl J Med1991;324:1565.
18.
Ip JH, Stein B., Fuster V., Badimon L.Antithrombotic therapy in cardiovascular diseases. Ann NYAcad Sci1991;614:289.
A Collaborative European Multicentre Study. A randomised trial of subcutaneous low molecular weight heparin (CY216) compared with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Thromb Haemost1991;65:251.
21.
Hull RD, Raskob GE, Pineo GF, et al. Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal vein-thrombosis. N Engl J Med1992;326:975.
22.
Nurmohamed MT, Rosendaal FR, Büller HR, et al. Low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta analysis. Lancet1992;340:152.
23.
Mätzsch T., Bergquist D., Hedner U., Østergaard P.Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers. Thromb Haemost1987;57:97.
24.
Winther K., Hillegass W., Tofler GH, et al. Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men. Am J Cardiol1992;70:1051.
